108 related articles for article (PubMed ID: 3511941)
1. Current understanding of the aetiology and clinical implications of cutaneous graft-versus-host disease.
Breathnach SM
Br J Dermatol; 1986 Feb; 114(2):139-43. PubMed ID: 3511941
[No Abstract] [Full Text] [Related]
2. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
[TBL] [Abstract][Full Text] [Related]
3. Immunological analysis of the skin in graft versus host disease.
Lampert IA; Janossy G; Suitters AJ; Bofill M; Palmer S; Gordon-Smith E; Prentice HG; Thomas JA
Clin Exp Immunol; 1982 Oct; 50(1):123-31. PubMed ID: 6756725
[TBL] [Abstract][Full Text] [Related]
4. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation.
Guyotat D; Mauduit G; Chouvet B; Kanitakis J; Van HV; Fiere D; Thivolet J
Transplantation; 1986 Mar; 41(3):340-2. PubMed ID: 3082048
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous immunological studies in diagnosis of acute graft-versus-host disease.
Dreno B; Milpied N; Harousseau JL; Stalder JF; Bureau B; Milpied B; Barriere H
Br J Dermatol; 1986 Jan; 114(1):7-15. PubMed ID: 3510654
[TBL] [Abstract][Full Text] [Related]
6. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.
Merad M; Hoffmann P; Ranheim E; Slaymaker S; Manz MG; Lira SA; Charo I; Cook DN; Weissman IL; Strober S; Engleman EG
Nat Med; 2004 May; 10(5):510-7. PubMed ID: 15098028
[TBL] [Abstract][Full Text] [Related]
7. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease and viral infections.
Gratama JW
Curr Opin Immunol; 1989 Aug; 1(6):1221-4. PubMed ID: 2553066
[No Abstract] [Full Text] [Related]
9. Abrogation of graft-versus-host disease following allotransplantation of cytotoxically deficient bone marrow across major histocompatibility barriers.
Selvaggi G; Inverardi L; Levy RB; Brendel MD; Spielman J; Mintz DH; Podack ER; Ricordi C
Ann N Y Acad Sci; 1995 Dec; 770():339-44. PubMed ID: 8597370
[No Abstract] [Full Text] [Related]
10. A two-phase pathogenesis of graft-versus-host disease in mice.
van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of cutaneous graft-versus-host disease.
Breathnach SM; Katz SI
Am J Dermatopathol; 1987 Aug; 9(4):343-8. PubMed ID: 2443033
[TBL] [Abstract][Full Text] [Related]
12. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
13. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
14. Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions.
Durakovic N; Bezak KB; Skarica M; Radojcic V; Fuchs EJ; Murphy GF; Luznik L
J Immunol; 2006 Oct; 177(7):4414-25. PubMed ID: 16982876
[TBL] [Abstract][Full Text] [Related]
15. A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation.
Tanaka K; Sullivan KM; Shulman HM; Sale GE; Tanaka A
J Dermatol; 1991 Jan; 18(1):11-7. PubMed ID: 2050901
[No Abstract] [Full Text] [Related]
16. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants.
Lever R; Turbitt M; Mackie R; Hann I; Gibson B; Burnett A; Willoughby M
Br J Dermatol; 1986 Feb; 114(2):161-70. PubMed ID: 2936371
[TBL] [Abstract][Full Text] [Related]
17. Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT).
van Els C; Bakker A; Zwaan F; van Rood JJ; Goulmy E
Transplant Proc; 1989 Feb; 21(1 Pt 3):2987-8. PubMed ID: 2468249
[No Abstract] [Full Text] [Related]
18. Perforin-deficient T cells can induce acute graft-versus-host disease after transplantation of MHC-matched or MHC disparate allogeneic bone marrow.
Levy RB; Baker M; Podack ER
Ann N Y Acad Sci; 1995 Dec; 770():366-7. PubMed ID: 8597376
[No Abstract] [Full Text] [Related]
19. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease.
Goulmy E; Gratama JW; Blokland E; Zwaan FE; van Rood JJ
Nature; 1983 Mar; 302(5904):159-61. PubMed ID: 6186923
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic graft-versus-host disease in man.
Sullivan KM
Int J Cell Cloning; 1986; 4 Suppl 1():42-93. PubMed ID: 2943828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
